Tag Archives: TEVA

Top 10 Medical Stocks To Buy For 2018

A recent survey from Accenture showed that 26% U.S. consumers have had their personal medical information stolen from technology systems, and half of those who experienced a breach were victims of medical identity theft. On average, those victims had to pay around $2,500 in out-of-pocket costs per incident.

The breaches were most likely to occur in hospitals (36%), followed by urgent-care....More>>>

penny stock trader

Netflix, Inc.(NASDAQ:NFLX) stock received several price target upgrades after the recent earnings.
Flickr

Shares of Los Gatos, California-basedvideo streaming giant, Netflix Inc (NASDAQ:NFLX) have been trending downwards after the company reported a miss on its subscriber numbers in its latest earnings report. Netflix stock is down by more than 5% since the earnings report, closing....More>>>

Best China Stocks To Watch For 2018

Lam Research (LRCX) soared to the top of the S&P 500 today after beating earnings forecasts and raising its fourth-quarter guidance.

Getty Images

Lam Researchgained 6.9% to $136.17 today, while the S&P 500 declined 0.2% to 2,338.17.

Credit Suisse analysts Farhan Ahmad and John Pitzer and argues that Lam Research’s “new trough is higher than [its] old....More>>>

HP Enterprise, Qualcomm Shamble into Wednesday’s 52-Week Low Club

September 6, 2017: Here are four stocks trading with heavy volume among 74 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by nearly 3 to 2 and on the Nasdaq advancers led decliners by about 4 to 3.

Hewlett Packard Enterprise Co. (NYSE: HPE) posted a new 52-week low of $13.60 on Wednesday, down about 3.1% from Tuesday’s closing....More>>>

Chesapeake Energy, Teva Slump into Monday’s 52-Week Low Club

August 28, 2017: Here are four stocks trading with heavy volume among 99 equities making new 52-week lows in Monday’s session. On the NYSE, decliners led advancers by about 8 to 7 and on the Nasdaq decliners led advancers by about 5 to 4.

Chesapeake Energy Corp. (NYSE: CHK) posted a new 52-week low of $3.59 on Monday, down about 5.3% from Friday’s closing price of $3.79.....More>>>

Chesapeake Energy, Teva Slump into Monday’s 52-Week Low Club

August 28, 2017: Here are four stocks trading with heavy volume among 99 equities making new 52-week lows in Monday’s session. On the NYSE, decliners led advancers by about 8 to 7 and on the Nasdaq decliners led advancers by about 5 to 4.

Chesapeake Energy Corp. (NYSE: CHK) posted a new 52-week low of $3.59 on Monday, down about 5.3% from Friday’s closing price of $3.79.....More>>>

Chesapeake Energy, Teva Slump into Monday’s 52-Week Low Club

August 28, 2017: Here are four stocks trading with heavy volume among 99 equities making new 52-week lows in Monday’s session. On the NYSE, decliners led advancers by about 8 to 7 and on the Nasdaq decliners led advancers by about 5 to 4.

Chesapeake Energy Corp. (NYSE: CHK) posted a new 52-week low of $3.59 on Monday, down about 5.3% from Friday’s closing price of $3.79.....More>>>

Top 10 Undervalued Stocks To Watch Right Now

Shares of Nevsun Resources (NYSEMKT:NSU) declined sharply, after the Q4 2016 earnings release. On Friday, shortly after the markets opened, Nevsun’s shares hit a low at $2.34. It is just shy of the multi-year low of $2.27, reached in January 2016. The share price managed to recover slightly and it closed at $2.72, which is close to the support level created during October 2016. Despite the....More>>>

high yield investments

SAN FRANCISCO The Amazon Go grocery store, now in the testing stage in Seattle, sounds like a dream come true for holiday shoppers waiting in long lines.

The underlying technology seems to be routed interra firma, however, a mix of cameras, microphones and the massive servers that Amazon uses to run its cloud computing service and power digital assistant Alexa.

The concept promises....More>>>

Valeant’s Revenue Growth Is At Risk

Source: Created by Author

Investment Thesis

As we can see from the above chart, since the fourth quarter of 2015, Valeant’s (NYSE: VRX) revenue declines are accelerating. From 2017 to 2021, many patents of the company’s key products will expire. Valeant admits that it faces intense competition from manufacturers of generic products. I expect VRX stock....More>>>